Millions of people walk around with a potential time bomb inside and most do not know it. Medtronic now has a new device on the market to fight the so-called Silent Killer, Abdominal Aortic Aneurysm or AAA.
As Valentine’s Day approaches it may be good to have your heart all aflutter. But, for up to three million Americans, it is a daily occurrence and that is not a good thing.
Twin Cities-based Medtronic has received government approval for the first heart pacemaker designed to be safely used with MRI scanners.
Medtronic said Monday that Chairman and CEO William A. Hawkins will step down in April after three years leading the world’s largest medical device manufacturer.
Medtronic’s fiscal second-quarter net income fell 35 percent as legal and other costs outpaced weak gains in medical device sales, but adjusted results met Wall Street expectations.
Millions of people with mild or moderate heart failure got good news Sunday, with studies showing a Pfizer drug and a device from Medtronic can boost survival and cut trips to the hospital by patients having trouble breathing.
Medtronic said Thursday it has agreed to pay $268 million to settle U.S. lawsuits and claims related to its Sprint Fidelis family of defibrillation leads which it recalled three years ago.